دورية
Willingness-to-pay for benefits associated with basal insulin treatment of type 2 diabetes
| العنوان: | Willingness-to-pay for benefits associated with basal insulin treatment of type 2 diabetes |
|---|---|
| المؤلفون: | Jendle, J., Ridderstråle, M., Torfvitt, O., Ericsson, Å, Larsen, S. |
| المصدر: | Journal of Medical Economics; April 2012, Vol. 15 Issue: 2 p261-263, 3p |
| مستخلص: | AbstractData from a 20-week trial comparing insulin detemir and neutral protamine Hagedorn (NPH) insulin in insulin-naïve people with type 2 diabetes were analyzed using willingness-to-pay (WTP) data, a proxy for patient preference. The advantages of insulin detemir relative to NPH insulin with respect to a lower hypoglycemia rate and less weight gain were associated with a value of €27.87 per month. |
| قاعدة البيانات: | Supplemental Index |
| تدمد: | 13696998 1941837X |
|---|---|
| DOI: | 10.3111/13696998.2011.644408 |